麻豆传媒

Researcher discusses weight outcomes for those taking semaglutide or liraglutide

More noteworthy research from the EASD 2024 meeting

Regulators will need to closely watch this new frontier

But significant weight loss reported for both

Saxenda group six times more likely to lose at least 5% of BMI

No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials

Similar improvements in weight loss and mental health in randomized trial

Reports of suicidal ideation higher when compared to other drugs in WHO database

From sourcing API to getting the final formulation just right

Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally

Health news and commentary gathered by 麻豆传媒 staff

Experts put SELECT trial findings in context

Health news and commentary gathered by 麻豆传媒 staff

Approximately one-fourth of new users in 2023 did not have type 2 diabetes